How has COVID-19 pandemic changed flu vaccination attitudes among an Italian cancer center healthcare workers?


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
31 12 2022
Historique:
pubmed: 7 10 2021
medline: 11 3 2022
entrez: 6 10 2021
Statut: ppublish

Résumé

A retrospective study was conducted among Italian cancer healthcare workers (HCWs) to describe how influenza vaccination attitudes have changed during the COVID-19 pandemic. The analysis was conducted on the last three influenza seasons (2018/19, 2019/20 and 2020/21). To account for different relationships and proximity with patients, the study population was grouped into three main professional categories: health personnel, administrative staff and technicians. Moreover, to explore the factors affecting the coverage of influenza vaccine, a multinomial regression analysis was performed.Over the years, the influenza vaccination uptake showed a gradual increase across the overall staff, the highest coverage (53.8%) was observed in the season 2020/21, in particular, for health personnel (57.7%). In general, males resulted in more adherent to vaccination campaigns; nevertheless, this gap decreased in the last season. A total of 28.6% workers were always vaccinated throughout the past three seasons, a remarkable 25.2% (mainly young and females) received for the first time the influenza vaccination in 2020/21.In this dramatic health crisis, the attitudes of HCWs toward flu vaccination have changed. The COVID-19 outbreak increased adherence to flu vaccination, reaching the highest coverage in the campaign 2020/21. However, further efforts should be made to achieve greater vaccination coverage.

Identifiants

pubmed: 34613881
doi: 10.1080/21645515.2021.1978795
pmc: PMC8903766
doi:

Substances chimiques

Influenza Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1978795

Références

BMC Health Serv Res. 2018 Nov 14;18(1):853
pubmed: 30428886
Hum Vaccin Immunother. 2020 May 3;16(5):1118-1124
pubmed: 31725352
J Pediatr. 2021 Jan;228:87-93.e2
pubmed: 32771480
Vaccines (Basel). 2020 Nov 30;8(4):
pubmed: 33266212
Healthcare (Basel). 2020 Aug 26;8(3):
pubmed: 32858784
Cancer. 2005 Aug 1;104(3):618-28
pubmed: 15973737
Early Hum Dev. 2020 Oct 1;:105215
pubmed: 33032876
Vaccine. 2019 Oct 31;37(46):6900-6906
pubmed: 31564452
MMWR Morb Mortal Wkly Rep. 2018 Sep 28;67(38):1050-1054
pubmed: 30260944
Med Lav. 2020 Nov 17;111(6):445-448
pubmed: 33311419
Vaccine. 2020 Oct 21;38(45):7049-7056
pubmed: 32980199
Vaccines (Basel). 2021 Mar 18;9(3):
pubmed: 33803755
Am J Infect Control. 2019 Feb;47(2):133-138
pubmed: 30293741
Int J Nurs Stud. 2021 Feb;114:103854
pubmed: 33326864

Auteurs

Lucia Bertoni (L)

Healthcare Administration, IRCCS-Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"- Irst, Meldola, Italy.

Andrea Roncadori (A)

Outcome Research, Healthcare Administration, IRCCS-Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"- Irst, Meldola, Italy.

Nicola Gentili (N)

Outcome Research, Healthcare Administration, IRCCS-Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"- Irst, Meldola, Italy.

Valentina Danesi (V)

Outcome Research, Healthcare Administration, IRCCS-Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"- Irst, Meldola, Italy.

Ilaria Massa (I)

Outcome Research, Healthcare Administration, IRCCS-Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"- Irst, Meldola, Italy.

Oriana Nanni (O)

Unit of Biostatistics and Clinical Trials, IRCCS-Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"- Irst, Meldola, Italy.

Mattia Altini (M)

Healthcare Administration, Azienda Unità Sanitaria Locale della Romagna, Ravenna, Italy.

Giovanni Gabutti (G)

Department of Medical Sciences, Università di Ferrara, Ferrara, Italy.

Maria Teresa Montella (MT)

Healthcare Administration, IRCCS-Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"- Irst, Meldola, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH